People

Will Biederman

Will Biederman, PhD, is the founder and chief executive officer of Bridge Neurotech. During graduate research at UC Berkeley, he developed a neural-interface chip used in Neuralink’s first implants. He later worked at Google X and Verily, where he led development of the Dexcom G7 continuous glucose monitor in partnership with Dexcom. He co-founded Forest Neurotech and led engineering and development of its Forest 1 functional ultrasound imaging device before founding Bridge in 2026 to develop non-invasive ultrasound brain-computer interfaces.